Treace Medical Concepts I... (TMCI)

NASDAQ: TMCI · Real-Time Price · USD

7.54

0.20 (2.72%)

At close: May 02, 2025, 2:15 PM

Treace Medical Concepts Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-55.74M	-49.53M	-42.81M	-20.55M	-3.67M	-4.26M
Depreciation & Amortization	8.42M	5.35M	2.13M	685K	1.21M	793K
Stock-Based Compensation	n/a	17.35M	8.11M	3.41M	919K	815K
Other Working Capital	-8.42M	6.24M	9.39M	4.19M	1.04M	3.76M
Other Non-Cash Items	10.16M	1.99M	7.73M	176K	221K	147K
Deferred Income Tax	n/a	n/a	n/a	419K	2.14M	145K
Change in Working Capital	n/a	-9.74M	-5.81M	-1.33M	-5.32M	-5.31M
Operating Cash Flow	-37.17M	-34.58M	-30.65M	-17.19M	-4.49M	-7.67M
Capital Expenditures	-11.59M	-11.46M	-14.84M	-2.71M	-1.07M	-1.21M
Cash Acquisitions	n/a	-20M	61.68M	n/a	n/a	n/a
Purchase of Investments	n/a	-169.87M	-63.41M	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	120.02M	1.73M	n/a	n/a	n/a
Other Investing Acitivies	35.38M	n/a	-61.68M	n/a	n/a	n/a
Investing Cash Flow	35.38M	-81.3M	-76.52M	-2.71M	-1.07M	-1.21M
Debt Repayment	n/a	n/a	19.61M	n/a	11.32M	20M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	160K	1.86M	1.2M	107.65M	185K	-261K
Financial Cash Flow	160K	109.38M	20.81M	107.65M	11.5M	19.74M
Net Cash Flow	-1.63M	-6.49M	-86.36M	87.75M	5.94M	10.86M
Free Cash Flow	-48.76M	-46.03M	-45.49M	-19.9M	-5.56M	-8.88M